Alyeska Investment Group has invested in 2 companies and its latest investment was I-MAB on Sep 03, 2020
FOLLOW STATUS
COMPANY
DESCRIPTION
AMOUNT
INVESTMENT DATE
ROUND
EXIT DATE
I-Mab is a Maryland-based clinical-stage biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases.
$418M
Sep 03, 2020
-
Fulcrum is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of genetic diseases.
$68.5M
Jun 09, 2020
-
Frequently Asked Questions about Alyeska Investment Group
What is Alyeska Investment Group investing in?
Alyeska Investment Group has invested in 2 companies including I-MAB and Fulcrum
What company did Alyeska Investment Group invest in?
Alyeska Investment Group invested in a total 2 companies including I-MAB and Fulcrum
What are the top 2 investments by Alyeska Investment Group?
The top companies in which Alyeska Investment Group invested are I-MAB and Fulcrum